Cite
Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas
MLA
Michel Wager, et al. “Correlation of Clinical Features and Methylation Status of MGMT Gene Promoter in Glioblastomas.” Journal of Neuro-Oncology, vol. 68, no. 3, Aug. 2004. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eaa69d17d510c8ce73c2d8454d66a925&authtype=sso&custid=ns315887.
APA
Michel Wager, J.-L. Blanc, T. Chantereau, Sophie Kusy, F. Lapierre, Lucie Karayan-Tapon, Joelle Guilhot, Benoit Bataille, & C.J. Larsen. (2004). Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas. Journal of Neuro-Oncology, 68(3).
Chicago
Michel Wager, J.-L. Blanc, T. Chantereau, Sophie Kusy, F. Lapierre, Lucie Karayan-Tapon, Joelle Guilhot, Benoit Bataille, and C.J. Larsen. 2004. “Correlation of Clinical Features and Methylation Status of MGMT Gene Promoter in Glioblastomas.” Journal of Neuro-Oncology 68 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eaa69d17d510c8ce73c2d8454d66a925&authtype=sso&custid=ns315887.